Strategy

Our Three-pronged Strategy

Focus on core competence
  • Identify the best disease targets
  • Develop unique best-in-class or first-in-class antibodies
  • Develop next generation technologies
Turn science into medicine – into real value
  • Generate differentiated antibody therapeutics with significant commercial potential
Build a profitable and successful biotech
  • Maintain a flexible and capital efficient model
  • Maximize relationships with partners
  • Retain ownership of select products
Three pronged strategy